Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Investigating the Role of CD133-Enriched Protrusion-Derived Extracellular Vesicles in Basal- Like Triple-Negative Breast Cancer Aggressiveness

ABSTRACT: This project investigates the role of CD133 in the production of protrusion-derived extracellular vesicles (PD-EVs) in triple-negative breast cancer (TNBC). By analyzing the molecular cargo of PD-EVs and their effects on tumor behavior, we aim to understand how they contribute to TNBC aggressiveness. Findings may reveal novel biomarkers or therapeutic targets, offering new insights into TNBC diagnosis, prognosis, and treatment strategies.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Cell Culture

SUBMITTER: Vanessa Masson

LAB HEAD: Damarys Loew

PROVIDER: PXD065555 | Pride | 2026-05-05

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	DesignPRIDE.xlsx	Xlsx
	X7344FD.msf	Msf
	X7344FD.raw	Raw
	X7346FD.msf	Msf
	X7346FD.raw	Raw

Items per page:

1 - 5 of 21

Similar Datasets

Harnessing hydrodynamics for high-yield production of extracellular vesicles from stem cells spheroids with specific cargo profiling

Project description:This study presents a novel method and device for the hydrodynamic production of extracellular vesicles (EVs) derived from biomimetic multicellular 3D spheroids, enabling high-throughput particle release that is 10 to 20 times higher than in non-stimulated conditions. The device facilitates the formation of spheroids from human mesenchymal stem cells (hMSCs), offering an all-in-one approach for both spheroid generation and EV release. Production times are reduced to just a few hours, with yield further increased by alternating periods of high hydrodynamic flow and spheroid recovery in a sequential production approach. Using this system, we explored the impact of hydrodynamic and starvation conditions on the protein cargo of EVs, identifying distinct protein markers through proteomics. Specifically, hydrodynamic stimulation enriched EVs in plasma membrane-derived and mitochondrial proteins, revealing divergent biogenesis pathways. Importantly, the produced EVs exhibited therapeutic properties, with demonstrated effects in wound healing, angiogenesis, and anti-inflammatory responses, some showing enhanced efficacy under hydrodynamic stimulation.

2026-02-19 | PXD059610 | Pride

Protrusion vs cell-body mRNA analysis by RNA-seq

Project description:Protrusion vs cell-body mRNA analysis by RNA-seq

| PRJEB6243 | ENA

Profiling and regulation of protrusion-enriched RNAs from mouse fibroblasts

Project description:Profiling and regulation of protrusion-enriched RNAs from mouse fibroblasts

| PRJNA324421 | ENA

Loss of EIF4G2 Mediates Aggressiveness in Distinct Endometrial Cancer Subpopulations with Adverse Outcomes in Patients

Project description:Low EIF4G2 protein expression was shown to have a poor OS of endometrial patients. Control and EIF4G2KD HEC-1A cells were sorted using CD133 merker to CD133+ and CD133- populations. These populations were taken to RNAseq and MS analysis to explore the mechanism.

2024-02-18 | GSE242717 | GEO

Identification of a shared persistence program in triple-negative breast cancer across treatments and patients

Project description:In this project, we investigated the evolution of the repertoire of FOSL1 partners upon 5-FU chemotherapy treatment in the MDA-MB-468 triple negatif breast cancer cell line with mass-spectrometry.

2025-09-19 | PXD066019 | Pride

CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma

Project description:Adoptive transfer of genetically or nanoparticle-engineered macrophages represents a promising cell therapy modality for treatment of solid tumor. However, the therapeutic efficacy is suboptimal without achieving a complete tumor regression, and the underlying mechanism remains elusive. Here, we discover a subpopulation of cancer cells with upregulated CD133 and programmed death-ligand 1 in mouse melanoma, resistant to the phagocytosis by the transferred macrophages. Compared to the CD133-PD-L1- cancer cells, the CD133+PD-L1+ cancer cells express higher transforming growth factor-β signaling molecules to foster a resistant tumor niche, that restricts the trafficking of the transferred macrophages by stiffened extracellular matrix, and inhibits their cell-killing capability by immunosuppressive factors. The CD133+PD-L1+ cancer cells exhibit tumorigenic potential. The CD133+PD-L1+ cells are further identified in the clinically metastatic melanoma. Hyperthermia reverses the resistance of CD133+PD-L1+ cancer cells through upregulating the ‘eat me’ signal calreticulin, significantly improving the efficacy of adoptive macrophage therapy. Our findings demonstrate the mechanism of resistance to adoptive macrophage therapy, and provide a de novo strategy to counteract the resistance.

2024-11-25 | GSE282386 | GEO

CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma.

2025-01-02 | GSE285529 | GEO

Characterization of extracellular vesicle cargos from mouse bone

Project description:EVs are known to play an important role in communication between bone cells. However, few studies have been carried out on EVs derived from osteocytes. The main aim of this project was to collect, characterize and evaluate the potential osteogenic properties of EVs derived from osteocytes.

2025-10-07 | PXD047653 | Pride

Proteomics analysis of Medulloblastoma

Project description:Medulloblastoma (MB) is the most common malignant brain tumor in children. It is a neuroectodermal tumor located in the cerebellum. International consensus recognizes four distinct subgroups of MBs including Wingless (WNT), Sonic Hedgehog (SHH), Group 3 (G3), and Group 4 (G4) with distinct molecular characteristics, prognoses, and mortality rates in patients. Here, we have compiled a large MB cohort encompassing 384 primary MB patient samples with methylome (450k/850k arrays), transcriptome (RNA-seq), proteome, phosphoproteome and metabolome.

2025-12-11 | PXD053458 | Pride

Mouse tumor cells secrete heterogenous particles including EVs, ENPs and VLPs into the extracellular medium - a proteome study

Project description:In addition to soluble proteins, cells secrete various types of membrane-enclosed extracellular vesicles (EVs: exosomes, ectosomes and others) and non-vesicular nanoparticles (ENPs) that are thought to play a role in intercellular communication. We exhaustively characterized the protein composition of secreted EVs and ENPs of murine tumor cell lines, including thorough separation of small EVs from co-isolated virus-like particles.

2023-11-27 | PXD039715 | Pride